Uniqure (QURE) Soars 275% on Stellar Clinical Trial for Huntington’s Disease
We recently published 10 Stocks Crushing Wall Street, AI Stocks Dominate. Uniqure NV (NASDAQ:QURE) is one of the top performers on Tuesday. Shares of Uniqure NV soared by as much as 275 percent on Wednesday to hit a new all-time high as investors cheered stellar results from the clinical trial of its drug candidate for Huntington’s disease. During the session, shares of the company soared to its highest price of 47.50 apiece. Uniq ...